{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:20:24Z","timestamp":1788790824125,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chan Zuckerberg Rare As One grant","award":["2021-238994 (5022)"],"award-info":[{"award-number":["2021-238994 (5022)"]}]},{"name":"Chan Zuckerberg Rare As One grant","award":["2021-238994 (5022)"],"award-info":[{"award-number":["2021-238994 (5022)"]}]},{"name":"Chan Zuckerberg Rare As One grant","award":["2021-238994 (5022)"],"award-info":[{"award-number":["2021-238994 (5022)"]}]},{"name":"Chan Zuckerberg Rare As One grant","award":["2021-238994 (5022)"],"award-info":[{"award-number":["2021-238994 (5022)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45789-3","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:38:00Z","timestamp":1774449480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyperphagia in craniopharyngioma- a real-world study from the international hypothalamic-pituitary brain tumors patient registry"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8992-0062","authenticated-orcid":false,"given":"Nathalie","family":"Kayadjanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2029-921X","authenticated-orcid":false,"given":"Eugenie A.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean S.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"45789_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/er.2013-1115","volume":"35","author":"HL M\u00fcller","year":"2014","unstructured":"M\u00fcller, H. L. Craniopharyngioma. Endocr. Rev. 35, 513\u2013543. https:\/\/doi.org\/10.1210\/er.2013-1115 (2014).","journal-title":"Endocr. Rev."},{"key":"45789_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000515347","volume":"93","author":"A Bereket","year":"2020","unstructured":"Bereket, A. Postoperative and long-term endocrinologic complications of craniopharyngioma. Horm. Res. Paediatr. 93, 497\u2013509. https:\/\/doi.org\/10.1159\/000515347 (2020).","journal-title":"Horm. Res. Paediatr."},{"key":"45789_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1515\/jpem.2006.19.1.15","volume":"19","author":"CC Pedreira","year":"2006","unstructured":"Pedreira, C. C. et al. Health related quality of life and psychological outcome in patients treated for craniopharyngioma in childhood. J. Pediatr. Endocrinol. Metab. 19, 15\u201324. https:\/\/doi.org\/10.1515\/jpem.2006.19.1.15 (2006).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"45789_CR4","first-page":"2072","volume":"70","author":"M Gillani","year":"2020","unstructured":"Gillani, M., Hassan, S., Abdullah, U. H., Saeed Baqai, M. W. & Shamim, M. S. Quality of life in children treated for craniopharyngiomas. J. Pak. Med. Assoc. 70, 2072\u20132074 (2020).","journal-title":"J. Pak. Med. Assoc."},{"key":"45789_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00005792-197507000-00002","volume":"54","author":"GA Bray","year":"1975","unstructured":"Bray, G. A. & Gallagher, T. F. Jr. Manifestations of hypothalamic obesity in man: A comprehensive investigation of eight patients and a reveiw of the literature. Medicine (Baltimore) 54, 301\u2013330 (1975).","journal-title":"Medicine (Baltimore)"},{"key":"45789_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/00019616-200205000-00008","volume":"12","author":"RH Lustig","year":"2002","unstructured":"Lustig, R. H. Hypothalamic obesity: The sixth cranial endocrinopathy. Endocrinologist 12, 210\u2013217. https:\/\/doi.org\/10.1097\/00019616-200205000-00008 (2002).","journal-title":"Endocrinologist"},{"key":"45789_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.wneu.2022.05.038","volume":"164","author":"M Castle-Kirszbaum","year":"2022","unstructured":"Castle-Kirszbaum, M., Shi, M. D. Y. & Goldschlager, T. Quality of life in craniopharyngioma: A systematic review. World Neurosurg. 164, 424-435.e422. https:\/\/doi.org\/10.1016\/j.wneu.2022.05.038 (2022).","journal-title":"World Neurosurg."},{"key":"45789_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.876770","volume":"13","author":"M Craven","year":"2022","unstructured":"Craven, M. et al. A survey of patient-relevant outcomes in pediatric craniopharyngioma: Focus on hypothalamic obesity. Front Endocrinol (Lausanne) 13, 876770. https:\/\/doi.org\/10.3389\/fendo.2022.876770 (2022).","journal-title":"Front Endocrinol (Lausanne)"},{"key":"45789_CR9","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/jcm4091774","volume":"4","author":"CL Roth","year":"2015","unstructured":"Roth, C. L. Hypothalamic obesity in craniopharyngioma patients: Disturbed energy homeostasis related to extent of hypothalamic damage and its implication for obesity intervention. J. Clin. Med. 4, 1774\u20131797. https:\/\/doi.org\/10.3390\/jcm4091774 (2015).","journal-title":"J. Clin. Med."},{"key":"45789_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000496564","volume":"91","author":"MJ Abuzzahab","year":"2019","unstructured":"Abuzzahab, M. J., Roth, C. L. & Shoemaker, A. H. Hypothalamic obesity: Prologue and promise. Horm. Res. Paediatr. 91, 128\u2013136. https:\/\/doi.org\/10.1159\/000496564 (2019).","journal-title":"Horm. Res. Paediatr."},{"key":"45789_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/endrev\/bnad033","volume":"45","author":"HW Gan","year":"2024","unstructured":"Gan, H. W., Cerbone, M. & Dattani, M. T. Appetite- and weight-regulating neuroendocrine circuitry in hypothalamic obesity. Endocr. Rev. 45, 309\u2013342. https:\/\/doi.org\/10.1210\/endrev\/bnad033 (2024).","journal-title":"Endocr. Rev."},{"key":"45789_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11102-008-0096-4","volume":"12","author":"M Lee","year":"2009","unstructured":"Lee, M. & Korner, J. Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans. Pituitary 12, 87\u201395. https:\/\/doi.org\/10.1007\/s11102-008-0096-4 (2009).","journal-title":"Pituitary"},{"key":"45789_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ecl.2020.05.009","volume":"49","author":"HL M\u00fcller","year":"2020","unstructured":"M\u00fcller, H. L. Management of hypothalamic obesity. Endocrinol. Metab. Clin. North Am. 49, 533\u2013552. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.009 (2020).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"Suppl 2","key":"45789_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/dom.15530","volume":"26","author":"CL Roth","year":"2024","unstructured":"Roth, C. L. & McCormack, S. E. Acquired hypothalamic obesity: A clinical overview and update. Diabetes Obes. Metab. 26(Suppl 2), 34\u201345. https:\/\/doi.org\/10.1111\/dom.15530 (2024).","journal-title":"Diabetes Obes. Metab."},{"key":"45789_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00351-z","volume":"8","author":"HL M\u00fcller","year":"2022","unstructured":"M\u00fcller, H. L. et al. Hypothalamic syndrome. Nat. Rev. Dis. Primers 8, 24. https:\/\/doi.org\/10.1038\/s41572-022-00351-z (2022).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"45789_CR16","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaf025","author":"HM van Santen","year":"2025","unstructured":"van Santen, H. M. & M\u00fcller, H. L. Management of acquired hypothalamic dysfunction and the hypothalamic syndrome; it is more than obesity. Endocr. Rev. https:\/\/doi.org\/10.1210\/endrev\/bnaf025 (2025).","journal-title":"Endocr. Rev."},{"key":"45789_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3233\/ben-1988-1107","volume":"1","author":"FG Flynn","year":"1988","unstructured":"Flynn, F. G., Cummings, J. L. & Tomiyasu, U. Altered behavior associated with damage to the ventromedial hypothalamus: A distinctive syndrome. Behav. Neurol. 1, 49\u201358. https:\/\/doi.org\/10.3233\/ben-1988-1107 (1988).","journal-title":"Behav. Neurol."},{"key":"45789_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2011.00060","volume":"2","author":"RH Lustig","year":"2011","unstructured":"Lustig, R. H. Hypothalamic obesity after craniopharyngioma: Mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne) 2, 60. https:\/\/doi.org\/10.3389\/fendo.2011.00060 (2011).","journal-title":"Front Endocrinol (Lausanne)"},{"key":"45789_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00381-005-1166-9","volume":"21","author":"HL M\u00fcller","year":"2005","unstructured":"M\u00fcller, H. L. et al. Functional capacity and body mass index in patients with sellar masses\u2013Cross-sectional study on 403 patients diagnosed during childhood and adolescence. Childs Nerv. Syst. 21, 539\u2013545. https:\/\/doi.org\/10.1007\/s00381-005-1166-9 (2005).","journal-title":"Childs Nerv. Syst."},{"issue":"Suppl 1","key":"45789_CR20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/oby.20646","volume":"22","author":"SB Heymsfield","year":"2014","unstructured":"Heymsfield, S. B. et al. Hyperphagia: Current concepts and future directions proceedings of the 2nd international conference on hyperphagia. Obesity (Silver Spring) 22(Suppl 1), S1-s17. https:\/\/doi.org\/10.1002\/oby.20646 (2014).","journal-title":"Obesity (Silver Spring)"},{"key":"45789_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000118545","volume":"21","author":"A Skorzewska","year":"1989","unstructured":"Skorzewska, A., Lal, S., Waserman, J. & Guyda, H. Abnormal food-seeking behavior after surgery for craniopharyngioma. Neuropsychobiology 21, 17\u201320. https:\/\/doi.org\/10.1159\/000118545 (1989).","journal-title":"Neuropsychobiology"},{"key":"45789_CR22","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1210\/clinem\/dgad488","volume":"109","author":"N Kayadjanian","year":"2023","unstructured":"Kayadjanian, N., Hsu, E. A., Wood, A. M. & Carson, D. S. Caregiver burden and its relationship to health-related quality of life in craniopharyngioma survivors. J. Clin. Endocrinol. Metab. 109, e76\u2013e87. https:\/\/doi.org\/10.1210\/clinem\/dgad488 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"45789_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98333","author":"EM Dykens","year":"2018","unstructured":"Dykens, E. M. et al. Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.98333 (2018).","journal-title":"JCI Insight"},{"key":"45789_CR24","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1210\/clinem\/dgad014","volume":"108","author":"JL Miller","year":"2023","unstructured":"Miller, J. L. et al. Diazoxide choline extended-release tablet in people with Prader-Willi Syndrome: A double-blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 108, 1676\u20131685. https:\/\/doi.org\/10.1210\/clinem\/dgad014 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"45789_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/oby.23928","volume":"32","author":"JL Miller","year":"2024","unstructured":"Miller, J. L. et al. Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study. Obes. (Silver Spring). 32, 252\u2013261. https:\/\/doi.org\/10.1002\/oby.23928 (2024).","journal-title":"Obes. (Silver Spring)"},{"key":"45789_CR26","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1210\/clinem\/dgad015","volume":"108","author":"E Roof","year":"2023","unstructured":"Roof, E. et al. Intranasal carbetocin reduces hyperphagia, anxiousness, and distress in Prader-Willi Syndrome: CARE-PWS phase 3 trial. J. Clin. Endocrinol. Metab. 108, 1696\u20131708. https:\/\/doi.org\/10.1210\/clinem\/dgad015 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"45789_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-024-09589-y","volume":"17","author":"EM Dykens","year":"2025","unstructured":"Dykens, E. M., Roof, E., Hunt-Hawkins, H. & Strong, T. V. Validation of the Food Safe Zone questionnaire for families of individuals with Prader-Willi syndrome. J. Neurodev. Disord. 17, 6. https:\/\/doi.org\/10.1186\/s11689-024-09589-y (2025).","journal-title":"J. Neurodev. Disord."},{"key":"45789_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248739","volume":"16","author":"N Kayadjanian","year":"2021","unstructured":"Kayadjanian, N. et al. Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome. PLoS One 16, e0248739. https:\/\/doi.org\/10.1371\/journal.pone.0248739 (2021).","journal-title":"PLoS One"},{"key":"45789_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/jnn.0b013e3181f8a59d","volume":"42","author":"DB Crom","year":"2010","unstructured":"Crom, D. B. et al. Health status in long-term survivors of pediatric craniopharyngiomas. J. Neurosci. Nurs. 42, 323\u2013328. https:\/\/doi.org\/10.1097\/jnn.0b013e3181f8a59d (2010).","journal-title":"J. Neurosci. Nurs."},{"key":"45789_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgac547","volume":"108","author":"H Arima","year":"2022","unstructured":"Arima, H. et al. Changing the name of Diabetes Insipidus: A position statement of the Working Group for Renaming Diabetes Insipidus. J. Clin. Endocrinol. Metab. 108, 1\u20133. https:\/\/doi.org\/10.1210\/clinem\/dgac547 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"45789_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1025440","volume":"13","author":"HM van Santen","year":"2022","unstructured":"van Santen, H. M., Spinedi, E. & Muller, H. L. Editorial: Hypothalamic obesity: Today and future. Front Endocrinol (Lausanne) 13, 1025440. https:\/\/doi.org\/10.3389\/fendo.2022.1025440 (2022).","journal-title":"Front Endocrinol (Lausanne)"},{"key":"45789_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad009","author":"HM van Santen","year":"2023","unstructured":"van Santen, H. M. et al. Diagnostic criteria for the hypothalamic syndrome in childhood. Eur. J. Endocrinol. https:\/\/doi.org\/10.1093\/ejendo\/lvad009 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"45789_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48024-5","volume":"13","author":"L Matesevac","year":"2023","unstructured":"Matesevac, L., Vrana-Diaz, C. J., Bohonowych, J. E., Schwartz, L. & Strong, T. V. Analysis of Hyperphagia Questionnaire for Clinical Trials (HQ-CT) scores in typically developing individuals and those with Prader-Willi syndrome. Sci. Rep. 13, 20573. https:\/\/doi.org\/10.1038\/s41598-023-48024-5 (2023).","journal-title":"Sci. Rep."},{"issue":"3","key":"45789_CR34","doi-asserted-by":"publisher","first-page":"A25","DOI":"10.1016\/j.jval.2015.03.154","volume":"18","author":"S Fehnel","year":"2015","unstructured":"Fehnel, S. et al. Development of the hyperphagia questionnaire for use in prader-willi syndrome clinical trials. Value in Health 18(3), A25 (2015).","journal-title":"Value in Health"},{"key":"45789_CR35","unstructured":"Cohen, J. Statistical power analysis for the behavioral sciences second edn (Routledge, 1988)."},{"key":"45789_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/jcm4030389","volume":"4","author":"AM Daubenb\u00fcchel","year":"2015","unstructured":"Daubenb\u00fcchel, A. M. & M\u00fcller, H. L. Neuroendocrine disorders in pediatric craniopharyngioma patients. J. Clin. Med. 4, 389\u2013413. https:\/\/doi.org\/10.3390\/jcm4030389 (2015).","journal-title":"J. Clin. Med."},{"key":"45789_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1159\/000509616","volume":"110","author":"EM Erfurth","year":"2020","unstructured":"Erfurth, E. M. Diagnosis, background, and treatment of hypothalamic damage in craniopharyngioma. Neuroendocrinology 110, 767\u2013779. https:\/\/doi.org\/10.1159\/000509616 (2020).","journal-title":"Neuroendocrinology"},{"key":"45789_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/pon.855","volume":"14","author":"G Poggi","year":"2005","unstructured":"Poggi, G. et al. Brain tumors in children and adolescents: Cognitive and psychological disorders at different ages. Psychooncology 14, 386\u2013395. https:\/\/doi.org\/10.1002\/pon.855 (2005).","journal-title":"Psychooncology"},{"key":"45789_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/mpo.2950180410","volume":"18","author":"B Lannering","year":"1990","unstructured":"Lannering, B., Marky, I., Lundberg, A. & Olsson, E. Long-term sequelae after pediatric brain tumors: Their effect on disability and quality of life. Med. Pediatr. Oncol. 18, 304\u2013310. https:\/\/doi.org\/10.1002\/mpo.2950180410 (1990).","journal-title":"Med. Pediatr. Oncol."},{"key":"45789_CR40","doi-asserted-by":"publisher","DOI":"10.1159\/000543544","author":"HM van Santen","year":"2025","unstructured":"van Santen, H. M. The central control of energy metabolism: hypothalamic obesity is not one disease. Horm. Res. Paediatr. https:\/\/doi.org\/10.1159\/000543544 (2025).","journal-title":"Horm. Res. Paediatr."},{"key":"45789_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1352\/0047-6765(2000)038<0163:CAUFCW>2.0.CO;2","volume":"38","author":"EM Dykens","year":"2000","unstructured":"Dykens, E. M. Contaminated and unusual food combinations: What do people with Prader-Willi syndrome choose?. Ment Retard 38, 163\u2013171. (2000).","journal-title":"Ment Retard"},{"key":"45789_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/genes10110898","author":"VE Kimonis","year":"2019","unstructured":"Kimonis, V. E. et al. Early diagnosis in Prader-Willi syndrome reduces obesity and associated co-morbidities. Genes https:\/\/doi.org\/10.3390\/genes10110898 (2019).","journal-title":"Genes"},{"key":"45789_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2022.106161","volume":"178","author":"S Zorn","year":"2022","unstructured":"Zorn, S., von Schnurbein, J., Schirmer, M., Brandt, S. & Wabitsch, M. Measuring hyperphagia in patients with monogenic and syndromic obesity. Appetite 178, 106161. https:\/\/doi.org\/10.1016\/j.appet.2022.106161 (2022).","journal-title":"Appetite"},{"key":"45789_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-024-00601-z","volume":"14","author":"SB Heymsfield","year":"2025","unstructured":"Heymsfield, S. B. et al. Defining hyperphagia for improved diagnosis and management of MC4R pathway-associated disease: A roundtable summary. Curr Obes Rep 14, 13. https:\/\/doi.org\/10.1007\/s13679-024-00601-z (2025).","journal-title":"Curr Obes Rep"},{"key":"45789_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-021-09373-2","volume":"13","author":"L Schwartz","year":"2021","unstructured":"Schwartz, L. et al. Behavioral features in Prader-Willi syndrome (PWS): Consensus paper from the International PWS Clinical Trial Consortium. J. Neurodev. Disord. 13, 25. https:\/\/doi.org\/10.1186\/s11689-021-09373-2 (2021).","journal-title":"J. Neurodev. Disord."},{"key":"45789_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41366-021-01043-6","volume":"46","author":"AH Shoemaker","year":"2022","unstructured":"Shoemaker, A. H. et al. Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonist. Int J Obes (Lond) 46, 623\u2013629. https:\/\/doi.org\/10.1038\/s41366-021-01043-6 (2022).","journal-title":"Int J Obes (Lond)"},{"key":"45789_CR47","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/oby.2007.216","volume":"15","author":"EM Dykens","year":"2007","unstructured":"Dykens, E. M., Maxwell, M. A., Pantino, E., Kossler, R. & Roof, E. Assessment of hyperphagia in Prader-Willi syndrome. Obesity 15, 1816\u20131826. https:\/\/doi.org\/10.1038\/oby.2007.216 (2007).","journal-title":"Obesity"},{"key":"45789_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000530863","volume":"97","author":"EC Hinton","year":"2024","unstructured":"Hinton, E. C. et al. Evaluating eating behaviour, energy homeostasis, and obesity in childhood-onset craniopharyngioma: A feasibility study. Horm. Res. Paediatr. 97, 80\u201393. https:\/\/doi.org\/10.1159\/000530863 (2024).","journal-title":"Horm. Res. Paediatr."},{"key":"45789_CR49","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1210\/clinem\/dgac678","volume":"108","author":"AH Shoemaker","year":"2023","unstructured":"Shoemaker, A. H. & Tamaroff, J. Approach to the patient with hypothalamic obesity. J. Clin. Endocrinol. Metab. 108, 1236\u20131242. https:\/\/doi.org\/10.1210\/clinem\/dgac678 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"45789_CR50","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ25-0408","author":"HL M\u00fcller","year":"2025","unstructured":"M\u00fcller, H. L. et al. Diagnostic criteria for acquired hypothalamic obesity - international expert guidance document. Endocr. J. https:\/\/doi.org\/10.1507\/endocrj.EJ25-0408 (2025).","journal-title":"Endocr. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45789-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:20:57Z","timestamp":1775125257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45789-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45789"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45789-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research study was conducted in accordance with the Declaration of Helsinki, reviewed and approved in accordance with applicable US Federal regulations governing the protection of human subjects (e.g., 45 CFR part 46, and\/or 21 CFR parts 50 and 56), and approved by the Central Institutional Review Board (NorthStar Review Board, # NB400191). All legal guardians\/legally authorized representatives of craniopharyngioma survivors completed an informed consent.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"11242"}}